Seegene Expands Precision Diagnostics for Women’s Health
SEOUL, South Korea, July 27, 2026 Seegene Inc., a global leader in molecular diagnostics, has introduced a comprehensive syndromic...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SEOUL, South Korea, July 27, 2026 Seegene Inc., a global leader in molecular diagnostics, has introduced a comprehensive syndromic...
FREMONT, Calif., July 28, 2026 Alamar Biosciences, Inc. has announced the commercial launch of the NULISAseqâ„¢ Immune 340 Panel,...
